Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience

Table 2

Multivariate Cox regression results of clinical variables found to be significant (𝑃≤0.05). *Signifies percentage of sample who required retransplantation.

	Range	Mean	𝑃 value	Change in OR
Transplants after 1988
Patient survival
Albumin at transplant	0.9–3.2	1.166	0.033	0.446
Allograft survival
Patient required retransplant	n/a	7.6%*	<0.00	49.02
Donor creatinine	0.30–15.0	1.38	0.004	1.32
Transplants after 2002
Patient survival
Total bilirubin at transplant	0.10–69.60	2.64	0.02	1.063
Albumin at transplant	1.40–5.20	3.83	0.011	0.480
Donor creatinine	0.3–15.0	1.46	0.004	1.288
Allograft survival
Patient required retransplant	n/a	4.5%*	<0.00	35.89
Total bilirubin at transplant	0.10–69.60	2.64	0.019	1.060
Albumin at transplant	1.40–5.20	3.83	0.006	0.455
Donor creatinine	0.3–15.0	1.46	0.004	1.308